Journals
Magazine:
MULTIDISCIPLINARY PAIN JOURNAL
ISSN:
2697-2263
This work is a review of the most relevant historical events that have occurred in the United States in relation to the use of opioids in the treatment of pain. This analysis is relevant to identify the events that may have caused or contributed to the onset and development of the current ¿epidemic¿ of opioid use in the United States. We also provide an analysis and discussion of the measures that have been taken in the United States in relation to this epidemic. This article corresponds to the third and final part of our analysis. We continue with the study of federal legislation implemented by government administrations in the United States to conclude with events up to the end of 2019.
Authors:
Tambone, V.; De Benedictis, A. (Corresponding author); Wathuta, J.; et al.
Magazine:
FRONTIERS IN MEDICINE
ISSN:
2296-858X
Year:
2022
Vol:
9
Pgs:
996408
Magazine:
JOURNAL OF OPIOID MANAGEMENT
ISSN:
1551-7489
Year:
2022
Vol:
18
N°:
3
Pp:
205 - 221
Objectives: To quantify the prevalence of opioid drug dependence and abuse in United States between 2017 and 2018 and identify which opioid molecules are associated with a higher level of dependence and abuse.
Design: National Survey on Drug Use and Health (NSDUH) data for 2017 and 2018 have been extracted. The variables related to painkillers were studied, the most important ones were selected, and several variable crosses were made. After the data were extracted, they were analyzed using Microsoft Excel and PivotTables, calculating the relative prevalence and percentages of patients with abuse and dependence.
Results: In total, 1.4 million people had dependence on pain relievers (PRs) in 2018. The last PR used was mostly hydrocodone (33 percent) and oxycodone (24 percent). The main reasons for using a PR without a doctor's prescription were relieving pain (48 percent), feeling good (16 percent), and relaxing or relieving tension (15 percent). Among patients who used a PR with a medical prescription, 1.5 million used it more frequently than prescribed, 1.2 million used it longer than prescribed, and 1.9 million used it in higher amounts than prescribed.
Conclusions: Abuse and dependence to PRs is lower than expected with over 1.4 million people in the United States having dependence in 2018 (0.6 percent point prevalence). Most cases of dependence are associated with misuse or abuse of prescriptions without medical supervision or the use of medications without a prescription of their own. Oxycodone and hydrocodone are the molecules most associated with dependence, misuse, abuse, and use without prescription. The age of onset of oxycodone misuse is very early (14 years old). Fentanyl does not seem relevant in any of the variables studied.
Magazine:
O.F.I.L.O. MAGAZINE.
ISSN:
1131-9429
Year:
2022
Vol:
32
N°:
1
Pp:
11 - 13
Magazine:
MULTIDISCIPLINARY PAIN JOURNAL
ISSN:
2697-2263
Year:
2021
Vol:
1
Ppgs:
112 - 122
This work is a review of the most relevant historical events that have occurred in the United States in relation to the use of opioids in the treatment of pain. This analysis is relevant to identify the events that may have caused or contributed to the onset and development of the current 'epidemic' of opioid use in the United States. We also provide an analysis and discussion of the measures that have been taken in the United States in relation to this epidemic. In this second part, we analyse developments and measures implemented in the United States between 2010 and 2018.
Magazine:
MULTIDISCIPLINARY PAIN JOURNAL
ISSN:
2697-2263
Year:
2021
Vol:
1
Ppgs:
51 - 60
This work is a review of the most relevant historical events that have occurred in the United States in relation to the use of opioids in the treatment of pain. This analysis is relevant to identify the events that may have caused or contributed to the onset and development of the current 'epidemic' of opioid use in the United States. We also provide an analysis and discussion of the measures that have been taken in the United States in relation to this epidemic. In this second part, we analyse developments and measures implemented in the United States between 2010 and 2018.
Magazine:
HEALTH LAW NEWS
ISSN:
1136-6869
Year:
2021
N°:
289
Pp:
117 - 121
This article looks at the case of Keira Bell, who sued Tavistock and Portman, the body that runs the gender identity change service for children in the UK, over the way it carried out her "gender transition" process.
Authors:
Ibañez del Pino, R.; Saiz Rodriguez, C.; Rivas, S.; et al.
Magazine:
BIOETHICS NOTES
ISSN:
2663-4910
Year:
2021
Vol:
4
N°:
1
Pp:
88 - 101
This work is based on the recognition of the important role that community pharmacists play in the health care of people suffering from a terminal process and their families and/or carers. There is no doubt that the committee, treatment and accompaniment of healthcare professionals in any life-threatening pathology is fundamental. The community pharmacist, as a healthcare agent, must be involved in these processes. However, they are often forgotten by the healthcare system, which thus wastes one of its most qualified professionals.
We are convinced that terminally ill patients and their relatives and/or carers would benefit greatly from greater involvement of pharmacists in their processes. For this reason, this article reflects on the benefits of including community pharmacists in the healthcare team caring for terminally ill patients.
Magazine:
O.F.I.L.O. MAGAZINE.
ISSN:
1131-9429
Year:
2021
Vol:
31
N°:
1
Pp:
7 - 8
Magazine:
MULTIDISCIPLINARY PAIN JOURNAL
ISSN:
2697-2263
Year:
2021
Vol:
1
Pgs:
5 - 12
Background: Opioid prescribing in recent years has been under scrutiny. To avoid a possible status epidemic in Spain it is necessary to study the prescribing dynamics in Spain. Our current analysis will focus on quantifying the level of prescribing by specialization program and indication.
Methods: We analysed the prescribing data provided by IQVIA© for all molecules and products classified in ATC-N2A (narcotic analgesics) and ATC-N2B (non-narcotic analgesic) between 2019 and 2020. The information has been provided by IQVIA Information, S.A., extracted on 23 October 2020 and contains 21,724 records. We extracted issue of prescriptions by molecule and issue of prescriptions by diagnosis grouped by therapeutic areas. We cross-analysed: prescriptions by diagnosis and by molecule, and prescriptions by molecule and specialization program. All calculations and data analysis were performed using Microsoft Excel IOS 2019.
Results: In 12 months, from June 2019 to June 2020, 3.2 million prescriptions for opioids from group N2A-ATC were prescribed in Spain. Most of the molecules prescribed were tapentadol (36 %), fentanyl (28 %) and oxycodone-naloxone (13 %). Eighty-one per cent of the fentanyl prescriptions were for the patch formulation. Primary care physicians were responsible for 73 % of prescriptions. Internal medicine specialists were relatively more relevant in prescribing fentanyl, while rheumatologists were relatively more important as prescribers of oxycodone-naloxone. The three most important indications were back pain (15 % of prescriptions), cancer (11 %) and osteoarthritis (10 %). By therapeutic area , 38 % of the prescriptions were for traumatological indications, 26 % for rheumatological diseases and 11 % for oncology.
Conclusion: The issue of prescriptions for potent opioids grew by 9.6% in the last 12 months (moving annual rate to June 2020) compared to the same period in 2019. Seventy-three percent of these prescriptions were concentrated in three molecules: tapentadol, fentanyl patch and oxycodone-naloxone. Primary care is the most relevant prescriber, with 73% of prescriptions. Oncological indications account for only 11% of all prescriptions, with the remaining 89% for non-oncological indications.
Magazine:
MULTIDISCIPLINARY PAIN JOURNAL
ISSN:
2697-2263
summary
Objectives: To quantify the level of use of opioid medicines in this general population survey , the level of adherence to the prescribed guidelines, the reason for use and the means by which they were obtained.
Methodology: Analysis of the raw data corresponding to the EDADES 2017 study, as well as the corresponding questionnaires. The EDADES study is a survey on alcohol, drugs and other addictions in Spain that has been carried out every two years since 1995 among the general population residing in households (15 to 64 years of age), with the data being nationally representative. The questions relevant to the purpose of this analysis were selected from 2.2 million data. After the categorisation and cleaning of data of the chosen variables, several dynamic tables were created to extract the desired information.
Results: In Spain, the 12-month prevalence of opioid medication use was 6.7% of the population aged 15-64 years. 87% of this use was associated with opioid use. Eighty-seven percent of this use was associated with tramadol and the rest was related to major opioids, with morphine being the most used with 8 % of patients. The age average of patients on opioids was between 39 and 53 years and the use of opioid medication was slightly higher among women. Ninety-two percent of people obtained the medication through their own prescription, while 4% obtained it from a pharmacy without a prescription and a further 3% obtained it from friends or relatives. Seventy-four per cent of patients had followed the dosage and duration of treatment guidelines prescribed by the doctor, while 19 % had used opioid medication in lower doses or for less time than prescribed and 5 % had used it in higher doses and for longer than prescribed.
Conclusions: Opioid use in Spain is low. Most patients use it under medical supervision and following the guidelines prescribed by the physician. It is necessary to follow up patients who obtain opioid drugs without their own prescription, as well as those who use them in a different way to that prescribed.
Palabras core topic: Prescription opioids, age, sex.
Magazine:
O.F.I.L.O. MAGAZINE.
ISSN:
1131-9429
Year:
2019
Vol:
29
N°:
4
Pp:
289 - 293
Magazine:
ANALYSIS
ISSN:
2386-3994
Year:
2019
N°:
24
Pp:
77 - 84
Magazine:
BIOETHICS NOTES
ISSN:
2663-4910
Year:
2019
Vol:
2
N°:
1
Pp:
19 - 29
In recent years, the consumption of antidepressant drugs has increased. Among the reasons that lead to this increase in the consumption of antidepressants are those included in the ¿medicalization¿, a process by which normal life situations have come to be treated from the medical point of view as the only remedy. Although antidepressants are of great value financial aid, they should not be the only tool, nor the first in all cases, to be resorted to for the treatment of depression. In many situations, the human being needs help to rationalize and channel the feelings that, in certain situations, can get out of control. This is where the psychologist has a fundamental role to play in preventing a normal status from reaching the pathological realm. Therefore, a good strategy to alleviate the medicalization of depression should include a greater presence of the psychologist in the healthcare team.
Magazine:
PERSON AND BIOETHICS
ISSN:
0123-3122
Year:
2019
Vol:
23
N°:
1
Pp:
49 - 63
For some years now, the collegial organisations of the pharmacy profession have been challenged, not only by external actors, but also by the professionals themselves. There is a certain critical response, especially in aspects that have to do with the role they should play in the development and the activity of the internship professional, in their domestic, external and internal purposes and in the characteristics they should possess as organisations at the service of these professionals and society. We understand that the development, revision and update of Bioethics in professional organisations, contributes to this transversal excellence in the profession, provokes a real knowledge of the same in all its dimensions and with the power to act in total freedom in the face of internal or external threats or restrictions.
Authors:
Francés ¿Causapé, M.C. (Corresponding author); López Guzmán, José; López¿ González, M.
Magazine:
ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA (ANNALS OF THE ROYAL NATIONAL ACADEMY OF PHARMACY)
ISSN:
1697-4271
Year:
2018
Vol:
84
N°:
Special Issue
Pp:
16 - 42
summary
review The geographical status of the Paracuellos de Jiloca Thermal Spa Centre, the oldest in Aragon, its historical background and its current status are presented. It is made accredited specialization to its owners, the composition Chemistry of its waters, as well as to the data referring to the date of its opening in 1847 and others concerning the therapeutic action of its waters.
Magazine:
BIOETHICS UPDATE
ISSN:
2395-938X
Year:
2018
Vol:
4
N°:
2
Pp:
103 - 118
summary
When a child is considered to have manifestations of gender dysphoria, parents are advised to begin the social transition to the new gender and to provide minors with puberty blockers, to recommend hormone cross-matching at the age of 16 and, finally, to proceed to surgery when they reach the age of majority. This protocol, which could be called official or politically correct, as it has the backing of different professional health associations, groups of affected people and, in some cases, the legislation itself, is being highly debated for different reasons such as, for example, the low fees of persistence of transsexualism in the transition from childhood to maturity, the side effects of the treatments, etc. Given this situation, any decision in this regard must be preceded by an act of prudence in which the good of the minor is protected. In this framework, the question arises as to what is in the best interest of the child.
Abstract
When a child is considered to have manifestations of gender dysphoria, parents are advised to begin the social transition to the new gender, and to provide the child with blockers of puberty and give cross-hormones at 16 years of age. Finally, when the age of majority comes, surgery is recommended. This protocol, which could be called official or politically correct, because of its support by different health professional associations, groups of people affected, and, in some cases, the legislation itself. These are all being discussed for various reasons, such as, for example, the low rates of persistence of transsexualism in the passage from childhood to maturity, and the side effects of treatments, etc. Given this situation, any decision making in this regard must be preceded by an act of prudence, aimed at guaranteeing the child's welfare. Within this framework it is important to ask what is really the best interest of the child.
Magazine:
PULSO (PAMPLONA)
ISSN:
1137-8913
Year:
2018
N°:
94
Pp:
30 - 33
Magazine:
BIOETHICS NOTEBOOKS
ISSN:
1132-1989
Year:
2018
Vol:
29
N°:
97
Pp:
247 - 256
The goal of the present work is to reflect on the opportunity and risk involved in the treatments proposed to address gender identity issues in this sector of the population. In most protocols for the care of minors with gender identity problems, pubertal suppression is proposed as the method of choice. The technique involves the administration of reversible GnRH agonists.
agonists to cause a suppression of the child's hormonal expression and, with it, the development of the child's gender-specific sexual characteristics. The timeliness or appropriateness of the systematic employment of reversible GnRH agonists may be questioned for several reasons. Firstly, because the diagnosis of transsexualism in minors is very complex and difficult, so there is a wide margin of error.
a wide margin of error. Secondly, because the suppression of puberty has direct consequences on development of the minor. Thirdly, because the aforementioned treatments have risks and side effects on minors, some of which have not been studied and are unknown, which should certainly be weighed up. Finally, because the medicines used are neither designed nor tested for the care of minors with gender identity problems. Therefore, they are used without being approved by drug regulatory agencies for that purpose.
Magazine:
ANNALS OF THE ROYAL ACADEMY OF PHARMACY
ISSN:
0034-0618
Year:
2017
Vol:
83
N°:
Special Issue
Pp:
14 - 37
A review is made of the geographical status of the
Balneario de San Nicolás, its historical and current
historical background and current status as well as
of its mineral-medicinal waters, its owners, the first
owners, the first analysis carried out by a pharmacist, the medical
by a pharmacist, the medical management and the
and the patients who have frequented it.
ABSTRACT:
An account of the geographical position of
Alhama de Almería'Spa is given, including a
brief history of it and its situation nowdays. An
particularly reference it is made about the
minero¿medicinal waters of this Spa, their
proprietaries, the pharmacist who made the
first chemical analysis, the sanitary direction
and the patients frequented it.
Magazine:
BIOETHICS NOTEBOOKS
ISSN:
1132-1989
Year:
2017
Vol:
XXVIII
N°:
93
Pp:
199 - 218
Surrogacy has an important economic dimension which, in recent years, has been further enhanced,
has been further enhanced in recent years. It is an
industry
industry which, on the other hand, takes advantage of women with low
of women with low economic resources. In the face of this, there is a major criticism, exercised by distin
-
In the face of this, there is considerable criticism from different groups, who refer to this sector with such questionable terms as "surrogacy industry", "baby farms", "baby farms", "surrogate
womb industry¿, ¿baby farms¿, ¿child factories¿, etc.
These criticisms are being strongly countered by the surrogacy centres.
They devote huge budgets to this with strategies that, based on large doses of sentimentalism, manage to transmit a positive image of the surrogacy process,
positive image of the process. The goal is to reassure users and society in general.
society in general. To this end, they distort the ethical and legal implications of the process; in particular, they deny the exploitation of women and the instrumentality of the process.
the exploitation of women and the instrumentalisation of children that this technique necessarily entails.
Magazine:
classroom FROM PHARMACY
ISSN:
1697-543X
Year:
2017
Vol:
13
N°:
120
Pp:
36 - 46
Community pharmacy is making a firm commitment to the care aspect.
to the care aspect. For some years now, there have been repeated
for a number of years now, there have been repeated references to this profile of the pharmacy profession.
pharmacy profession. Thus, in 2103, the well-remembered Francisco Martinez
called for the interest of a specialization program in health care pharmacy1.
care pharmacy1. For his part, in the same year, Diego Marro
centred his speech of admission to the Academy of Pharmacy of the Kingdom of Aragon2 on the
of the Kingdom of Aragon2 on the ¿mission statement professional pharmacist¿.
the health care pharmacist¿. Lastly, and to be no more exhaustive,
Suffice it to say that Portalfarma, the portal of the committee General de
Colegios Oficiales de Farmacéuticos, has a entrance dedicated to the
to health care pharmacy3. It is true that under the umbrella
under the umbrella of "health care pharmacy" there are different visions, ranging from
some that appear to be clear about the aims they pursue to others that seem to identify the
others that seem to identify the means with the ends. In any
In any case, what they all have in common is the repositioning of the
the pharmaceutical profession vis-à-vis the patient. This is undoubtedly appropriate and desirable
is appropriate and convenient for both professionals and patients.
for both professionals and patients.
This new status of dialogue with the patient, as pointed out by
Jesús Aguilar, in the report Farmacia Asistencial, is based on the fact that
is based on the fact that ¿patients need and demand
a Pharmacy focused on the patient¿4.
Based on this premise, it is worth asking whether this approach can be reduced to offering more services to patients.
is reduced to offering more services to patients or does it go beyond that?
and whether it also contemplates the co
Magazine:
ANNALS OF THE ROYAL ACADEMY OF PHARMACY
ISSN:
0034-0618
Year:
2016
Vol:
82
N°:
5
Pp:
12 - 37
review The geographical status of the Villavieja Spa, its historical background and status are presented. The owners, the first chemical analysis of the mineral-medicinal waters of the spa, the medical directors, the patients who have frequented the spa and references to the therapeutic action of its waters are mentioned at accredited specialization .
Magazine:
classroom FROM PHARMACY
ISSN:
1697-543X
Year:
2016
Vol:
12
N°:
114
Pp:
40 - 46
Magazine:
classroom FROM PHARMACY
ISSN:
1697-543X
Year:
2016
Vol:
12
N°:
113
Pp:
34 - 41
Magazine:
ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA (ANNALS OF THE ROYAL NATIONAL ACADEMY OF PHARMACY)
ISSN:
1697-4271
Year:
2015
Vol:
81
N°:
5
Pp:
12 - 32
There is a review of the geographical status of the Spa of the Villa de Olmedo, of the historical background of the same and status current. accredited specialization The owners, the first chemical analysis of the mineral-medicinal waters of this Spa and data referring to the date of its opening in 2006 and others referring to the therapeutic action of its waters.
Magazine:
ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA (ANNALS OF THE ROYAL NATIONAL ACADEMY OF PHARMACY)
ISSN:
1697-4271
Year:
2015
Vol:
81
Pgs:
12 - 32
Magazine:
LUMEN
ISSN:
1209-3696
Year:
2015
Vol:
11
Pgs:
47 - 58
It is common to observe that, in the health attendance , illness is treated technically, without taking into account the sick person who is going through the process, from his or her own unique and unrepeatable originality, thus stripping the ailment of its character staff and historical character; and the subject, reduced to an organism. However, illness is not only a biochemical problem or an alteration of the subject's biology; it is a humanising and humanising experience that affects the human being as a whole. It is therefore important to look at the person and re-humanise the health care attendance in order to provide holistic coverage for the suffering subject. In this re-humanisation, intentional presence plays an important role, understood as the relationship in which the healthcare staff and the patient come to form a unit of dialogue based on the meeting plenary session of the Executive Council between two people.
Magazine:
classroom FROM PHARMACY
ISSN:
1697-543X
Year:
2014
Vol:
10
N°:
105
Pp:
31 - 42
Medicines are goods that contribute to the realisation of the right to health protection. In order to preserve this right, the different States establish legal measures, generally at the highest level. Thus, for example, the Spanish Constitution recognises, in article 43.1, the right to health protection. The different health services and medicines favour the prevention and treatment of illnesses and, therefore, it is logical that they form part of the benefits offered by the health administration. Moreover, the financing of health services and pharmaceuticals reflects society's recognition that health is a fundamental right to which all groups of the population should have access4 . In this sense, article 88.1 of Law 29/20065 "recognises the right of all citizens to obtain medicines under equal conditions throughout the National Health System".
Health System¿. In this way, the public health system assumes all or part of the economic cost to guarantee the right to obtain the medicines, products or health services necessary to promote, preserve or restore health. Public funding is accompanied by price intervention to ensure that expense is sustainable for the public health system.
On the basis of these premises, which are generally accepted by all social actors, a number of questions are raised.
Magazine:
PERSON AND BIOETHICS
ISSN:
0123-3122
Year:
2014
Vol:
18
N°:
2
Pp:
170 - 183
For decades, both health authorities and health professionals have placed special emphasis on the importance of the relationship between food and health maintenance. However, it should be noted that, although this link is not new, in recent years it has gone beyond the strictly food-nutritional framework , leading to a proliferation of food products claiming health-related claims. In view of this status, and in order to protect consumers, the legislator in the European Union has created a legal concept while, in the scientific field, research into the health properties of these foods has continued. In this context, the "medicalisation of food" has developed, not without controversy.
Magazine:
BIOETHICS NOTEBOOKS
ISSN:
1132-1989
Year:
2014
Vol:
XXV
N°:
84
Pp:
273 - 284
People who are overweight have an increased risk of certain chronic diseases and premature death. However, the physiological consequences are not limited to symptoms and health signs, but transcend into the social field. In fact, the stigmatisation and discrimination suffered by obese people has become evident in many areas (work, family, education, etc.), which can contribute to reducing the patient's quality of life. From a gender perspective, at bibliography there is evidence that the undesirable effects of obesity affect women more than men. To minimise the impact of obesity, people are proactively adopting methods to lose weight. However, the solution to this problem does not lie in medication but in lifestyle changes and non-discriminatory aesthetic role models proposal . It should also be recognised that the complex aetiology of obesity can help to reduce weight stigma and the negative consequences of this condition.
Magazine:
classroom FROM PHARMACY
ISSN:
1697-543X
Year:
2013
Vol:
9
N°:
98
Pp:
31 - 36
Magazine:
CUADERNOS DE BIOETICA
ISSN:
0328-8390
Year:
2013
Vol:
XXIV
Ppgs:
79 - 90
Awareness of the current importance of Bioethics has led to its progressive introduction in the university panorama educational . However, its incorporation into the different levels of teaching has been slower than might be expected, fundamentally in the undergraduate training and Degree. This article reflects on the current status of personalist bioethics in university curricula. It starts with an analysis of the implementation of Bioethics at Degree and postgraduate level and, subsequently, an exploration of the factors that may favour or hinder its development. The conclusion reached is that the teaching and learning of Bioethics in the university environment requires a rigorous research with a strong theoretical base based on the personalist Philosophy , understood as a philosophical school of the 20th century.
Magazine:
classroom FROM PHARMACY
ISSN:
1697-543X
Year:
2013
Vol:
9
N°:
95
Pp:
47 - 55
Magazine:
BIOETHICS NOTEBOOKS
ISSN:
1132-1989
Year:
2012
Vol:
23
N°:
78
Pp:
253 - 267
Surrogate motherhood is a topic that is currently very complex. For some, it is a lawful internship , which should be legally admissible. In contrast, Western legal systems have traditionally understood that, in contrast to the free disposal of objects, persons, including the human body, its organs and most essential functions, cannot be traded. Thus, there are limits to the freedom of individuals to enter into contracts for mutual benefit. With regard to the child, the legalisation of surrogate motherhood means to
surrogacy entails the commodification of filiation, since it will ultimately depend, written request, on an economic transaction. On the other hand, experience has shown that the child is left in a very vulnerable position, given that his or her status depends on the clauses established in the contract, which in no way ensures the protection of his or her interests and rights. Therefore, it can be concluded that the wishes of infertile couples should certainly be listened to by society. However, not all the wishes of adults should be considered as rights, especially if this implies harming the dignity and rights of other subjects involved, especially the most vulnerable women and children.
Magazine:
BIOETHICS NOTES
ISSN:
2078-4457
Year:
2012
Vol:
3
N°:
3
Pp:
63 - 69
Objectives: To analyse the Degree homogeneity of the financial report included in the contracts of Spanish healthcare centres participating in clinical trials (CT) with medicinal products in order to detect points of potential conflict of interest in the clinical research .Material and methods: A self-questionnaire was used to analyse the financial report of 40 contracts, 31 corresponding to randomly selected private and public health centres and 9 corresponding to autonomous communities with a single contract model . Results: The team researcher, in 97.5% of the cases (39 contracts), is the main recipient of the financial remuneration for participating in a clinical trial. The percentage provided differs according to the centre, being higher if it is public (p=0.021) but unspecified in 50% of the contracts. In 38 of the 40 contracts analysed, a list of prices for complementary tests is not provided. In 57.5% (23 contracts), it is not specified whether patient costs are paid by the sponsor. In 77.5% (31 cases) it is not specified whether the costs of CE-related meetings are included in the financial report . Conclusions: There is a high degree of heterogeneity in the content of the financial report . model The implementation of a financial report that includes a fixed amount of financial remuneration for each patient recruited by the sponsor for all participating centres could reduce inequalities between centres and conflicts of interest, and would also increase the transparency and quality of the CEs.
Magazine:
classroom FROM PHARMACY
ISSN:
1697-543X
Year:
2011
Vol:
7
N°:
78
Pp:
46 - 56
Magazine:
Pharmaceuticals Policy and Law
ISSN:
1389-2827
Year:
2011
Vol:
13
N°:
1-2
Pp:
57 - 60
The article focuses on the safety, quality, economic aspects of the policy toward the use of generic drugs with respect to the Directive 2004/27 established by the European Union (EU) countries through the European Medicines Agency (EMA).
Magazine:
BIOETHICS NOTES
ISSN:
2078-4457
Year:
2011
Vol:
2
Ppgs:
74 - 80
Conscientious objection consists of an individual's failure to comply with a legal obligation, the performance of which would cause serious harm to his or her conscience. Conscientious objection, as the external dimension of ideological and conscientious freedom, is an essential pillar of any democratic society. On the international rules and regulations , references to freedom of conscience and conscientious objection are increasingly frequent. The reason for this can be found in the growing concern to find a balance and integration between majorities and minorities.
The pharmacist, like any other professional, needs freedom in his or her professional practice, a freedom that allows him or her to reach his or her true vocation, the deepest demands of his or her being. Every pharmacist is a moral agent and responds to any action or omission with his or her own being, the pharmacist's ideal of life permeates all his or her activity and, in coherence, it is logical that he or she should carry out those acts which he or she considers good and avoid those which he or she considers harmful. This is at the heart of the question of the pharmacist's freedom of conscience.
Magazine:
Bioethics Notebooks
ISSN:
1132-1989
Year:
2011
Vol:
22
N°:
75
Pp:
309 - 324
Magazine:
BIOETHICS NOTEBOOKS
ISSN:
1132-1989
Year:
2011
Vol:
22
N°:
75
Pp:
169 - 184
The levonorgestrel morning-after pill (SDP) began to be used in the last quarter of the twentieth century. However, it was not until the beginning of this century that it began to expand and become widely marketed. This process of implementation has been favoured by health policies that have led to the elimination of barriers to its use. To this end, sociological, scientific, statistical, etc. data have been used, which, on numerous occasions, have been presented in a biased or partial way. The veracity of the information on PDS provided by health administrations, pharmaceutical laboratories and other social agents is called into question in several areas - mechanism of action, side effects, fees of pregnancies, etc. -. This article focuses on the mechanism of action. This decision is based on the fact that a broader discussion would go beyond the possibilities of specifying the work and that, at the same time, the mechanism of action is the most discussed aspect and source of greatest discrepancies. The relevance of determining whether PDS is a product that acts only before ovulation or whether it also has an effect on the human embryo is of great importance.
Magazine:
classroom de la Farmacia (Printed version)
ISSN:
1697-543X
Year:
2010
Vol:
6
N°:
70
Pp:
45 - 56
Magazine:
European Journal of Obstetrics & Gynecology and Reproductive Biology
ISSN:
0301-2115
Year:
2010
Vol:
151
N°:
1
Pp:
56 - 61
Objective: Some methods of family planning, such as oral contraceptives, emergency pill or intrauterine device, may occasionally work after fertilization. These effects may be important to some women. We explored Spanish women's attitudes towards contraceptive choices that may have occasional post-fertilization mechanisms of action. Study design: Cross-sectional study in a Spanish representative sample of 848 potentially fertile women, aged 18¿49. Data were collected using a 30-item questionnaire about family planning. Logistic regression was used to identify variables associated with women's attitudes towards post-fertilization effects. Results: The majority of women were married, had completed high school and had at least one child. Forty-five percent of women would not consider using a method that may work after fertilization and 57% would not consider using one that may work after implantation. Forty-eight percent of the sample would stop using a method if they learned that it sometimes works after fertilization, increasing to 63% when referring to a method that sometimes works after implantation. Women who believe that human life begins at fertilization, those who believe it is important to distinguish between spontaneous and induced embryo losses and women who report having a religion were less likely to consider the use of a method with some post-fertilization effects.Conclusion:The possibility of post-fertilization effects may influence Spanish women's choice of a family planning method. Information about mechanisms of action of birth control methods should be disclosed to women so that they can make informed choices.
Magazine:
BIULETYN STOWARZYSZENIA FARMACEUTÓW KATOLICKICH POLSKI
ISSN:
1509-698-X
Year:
2010
Vol:
36-37
Ppgs:
153 - 164